[en] TEMTIA X, the tenth symposium organized by the EMT international Association (TEMTIA) took place in Paris on November 7th-10th, 2022. Similarly to the previous meetings, it reviewed most recent aspects of the epithelial-mesenchymal transition, a cellular process involved during distinct stages of development, but also during wound healing and fibrosis to some level. EMT steps are likewise typically described with various extents during tumor cell progression and metastasis. The meeting emphasized the intermediate stages involved in the process and their potential physiological or pathological importance, taking advantage of the expansion of molecular methods at single cell level. It also introduced new descriptions of EMT occurrences during early embryogenesis. In addition, sessions explored how EMT reflects cell metabolism and how the process can mingle with immune response, particularly during tumor progression, providing new targets, that were discussed, among others, for cancer therapy. Finally, it introduced a new perception of EMT biological meaning based on an evolutionary perspective. The meeting integrated the TEMTIA general assembly , allowing general discussion about the future of the association, starting with the site of the next meeting, now decided to take place in Seattle (US), late 2024.
Disciplines :
Oncology
Author, co-author :
Savagner, Pierre
Brabletz, Thomas
Cheng, Chonghui
Gilles, Christine ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Hong, Tian
Polette, Myriam
Sheng, Guojun
Stemmler, Marc P
Thompson, Erik W
Language :
English
Title :
Twenty years of EMT: A state of the field from TEMTIA X.
Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6): 341–52.
Bergers G, Fendt S-M. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162–80.
Müller S, Sindikubwabo F, Cañeque T, Lafon A, Versini A, Lombard B, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12(10):929–38.
Bhattacharya D, Khan B, Simoes-Costa M. Neural crest metabolism: at the crossroads of development and disease. Dev Biol. 2021;475: 245–55.
Gouignard N, Bibonne A, Mata JF, BajancaBerki FB, Barriga EH, et al. Paracrine regulation of neural crest EMT by placodal MMP28. PLoS Biol. 2023;21(8):e3002261.
Campbell K, Lebreton G, Franch-Marro X, Casanova J. Differential roles of the Drosophila EMT-inducing transcription factors Snail and Serpent in driving primary tumour growth. PLoS Genet. 2018;14(2):e1007167.
Hultgren NW, Fang JS, Ziegler ME, Ramirez RN, Phan DTT, Hatch MMS, et al. Slug regulates the Dll4-Notch-VEGFR2 axis to control endothelial cell activation and angiogenesis. Nat Commun. 2020;11(1):5400.
Zhao J, Patel J, Kaur S, Sim SL, Wong HY, Styke C, et al. Sox9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitors. Nat Commun. 2021; 12(1):2564.
Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, et al. Plasticity of lgr5-negative cancer cells drives metastasis in colorectal cancer. PLoS Biol. 2020;26(4):569–78.e7.
Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–26.
Clark AG, Maitra A, Jacques C, Bergert M, Pérez-González C, Simon A, et al. Self-generated gradients steer collective migration on viscoelastic collagen networks. Nat Mater. 2022;21(10):1200–10.
Fattet L, Jung HY, Matsumoto MW, Aubol BE, Kumar A, Adams JA, et al. Matrix rigidity controls epithelial-mesenchymal plasticity and tumor metastasis via a mechanoresponsive EPHA2/LYN complex. Dev Cell. 2020;54(3):302–16.e7.
Tsirigoti C, Ali MM, Maturi V, Heldin CH, Moustakas A. Loss of SNAI1 induces cellular plasticity in invasive triple-negative breast cancer cells. Cell Death Dis. 2022;13(9):832.
Schuhwerk H, Menche C, Armstark I, Gupta P, Fuchs K, van Roey R, et al. ZEB1-dependent modulation of fibroblast polarization governs inflammation and immune checkpoint blockade sensitivity in colorectal cancer. bioRxiv. 2023.
Kim I-K, Diamond M, Yuan S, Kemp S, Li Q, Lin J, et al. Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. Res Sq. 2023.
Dongre A, Rashidian M, Eaton EN, Reinhardt F, Thiru P, Zagorulya M, et al. Direct and indirect regulators of epithelial-mesenchymal transition-mediated immunosuppression in breast carcinomas. Cancer Discov. 2021;11(5):1286–305.
Terry S, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, et al. New insights into the role of EMT in tumor immune escape. Mol Oncol. 2017;11(7):824–46.
Tan X, Xiao G-Y, Wang S, Shi L, Zhao Y, Liu X, et al. EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. J Clin Invest. 2023;133(7):e165863.
Moorman A, Cambuli F, Benitez E, Jiang Q, Xie Y, Mahmoud A et al. Progressive Plasticity during colorectal cancer metastasis. bioRxiv. 2023.08.18.2023.08.18.553925.
Qiu X, Zhang Y, Martin-Rufino JD, Weng C, Hosseinzadeh S, Yang D, et al. Mapping transcriptomic vector fields of single cells. Cell. 2022;185(4):690–711.e45.
Pang QY, Tan TZ, Sundararajan V, Chiu YC, Chee EYW, Chung VY, et al. 3D genome organization in the epithelial-mesenchymal transition spectrum. Genome Biol. 2022; 23(1):121.
Johnson KS, Hussein S, Chakraborty P, Muruganantham A, Mikhail S, Gonzalez G, et al. CTCF expression and dynamic motif accessibility modulates epithelial-mesenchymal gene expression. Cancers. 2022;14(1):209.
Karacosta LG, Anchang B, Ignatiadis N, Kimmey SC, Benson JA, Shrager JB et al. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nat Commun. 2019;10(1): 5587.
Voon DC, Huang RY, Jackson RA, Thiery JP. The EMT spectrum and therapeutic opportunities. Mol Oncol. 2017;11(7):878–91.
Cheng C, Wang J, Xu P, Zhang K, Xin Z, Zhao H, et al. Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer. Nat Cancer. 2022;3(5): 565–80.
Raymond JH, Aktary Z, Larue L, Delmas V. Targeting GPCRs and their signaling as a therapeutic option in melanoma. Cancers. 2022;14(3):706.
Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, et al. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature. 2023;620(7973): 402–8.
Bar-Hai N, Ishay-Ronen D. Engaging plasticity: differentiation therapy in solid tumors. Front Pharmacol. 2022;13:944773.
Wright BA, Kvansakul M, Schierwater B, Humbert PO. Cell polarity signalling at the birth of multicellularity: what can we learn from the first animals. Front Cell Dev Biol. 2022;10:1024489.
Brunet T, Booth DS. Cell polarity in the protist-to-animal transition. Curr Top Dev Biol. 2023;154:1–36.
Pradeu T, Daignan-Fornier B, Ewald A, Germain PL, Okasha S, Plutynski A, et al. Reuniting philosophy and science to advance cancer research. Biol Rev Camb Philos Soc. 2023;98(5):1668–86.
